↓ Skip to main content

Cochrane Database of Systematic Reviews

Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome

Overview of attention for article published in Cochrane database of systematic reviews, April 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
7 tweeters
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
133 Mendeley
Title
Monoamine oxidase inhibitors (MAOIs) for fibromyalgia syndrome
Published in
Cochrane database of systematic reviews, April 2012
DOI 10.1002/14651858.cd009807
Pubmed ID
Authors

Sera Tort, Gerard Urrútia, María Betina Nishishinya, Brian Walitt

Abstract

Fibromyalgia (FM) syndrome is a chronic condition of unknown aetiology characterised by musculoskeletal pain that often co-exists with sleep disturbance, cognitive dysfunction and fatigue. Patients often report high disability levels and poor quality of life. Since there is no specific treatment that alters the pathogenesis of FM, drug therapy focuses on pain reduction and improvement of other bothersome symptoms.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 133 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Spain 1 <1%
Australia 1 <1%
Unknown 130 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 28 21%
Student > Doctoral Student 18 14%
Student > Ph. D. Student 13 10%
Student > Bachelor 13 10%
Researcher 12 9%
Other 26 20%
Unknown 23 17%
Readers by discipline Count As %
Medicine and Dentistry 49 37%
Nursing and Health Professions 14 11%
Psychology 14 11%
Neuroscience 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Other 20 15%
Unknown 25 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2019.
All research outputs
#3,770,318
of 21,332,163 outputs
Outputs from Cochrane database of systematic reviews
#6,283
of 12,087 outputs
Outputs of similar age
#23,993
of 141,841 outputs
Outputs of similar age from Cochrane database of systematic reviews
#36
of 84 outputs
Altmetric has tracked 21,332,163 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,087 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.0. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 141,841 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.